Medpace Holdings (MEDP) Receivables - Other (2015 - 2026)

Medpace Holdings has reported Receivables - Other for 12 years, with the latest figure at $24.2 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Other rose 282.7% year-over-year to $24.2 million; the trailing twelve-month figure through Mar 2026 stood at $24.2 million (up 282.7% YoY), and the FY2025 full-year result was $25.4 million, up 374.14% from the prior year.
• Receivables - Other for Q1 2026 stood at $24.2 million, down from $25.4 million in the prior quarter.
• The five-year high for Receivables - Other was $43.8 million in Q2 2022, with the low at $5.3 million in Q4 2024.
• Historically, Receivables - Other has averaged $23.5 million across 5 years, with a median of $24.2 million in 2026.
• Annual changes were most pronounced in 2024 — Receivables - Other plunged 81.09% — and 2025, when it soared 374.14%.
• Medpace Holdings' Receivables - Other stood at $40.4 million in 2022, then plunged by 44.38% to $22.5 million in 2023, then plunged by 76.21% to $5.3 million in 2024, then soared by 374.14% to $25.4 million in 2025, then decreased by 4.54% to $24.2 million in 2026.
• The last three Receivables - Other figures came in at $24.2 million (Q1 2026), $25.4 million (Q4 2025), and $10.7 million (Q3 2025), per Business Quant data.